IntegraGen (FR0010908723 : ALINT - PEA-SME Eligible) (Paris:ALINT), a company specializing in the decoding of the human genome with a focus on producing interpretable genomic analyzes for academic and private laboratories and developing diagnostic tools in oncology, today announced that it has earned ISO 13485:2016 certification from Bureau Veritas. This certification indicates that the company’s quality management systems meet the specific standards required for the design, development, production and marketing of in vitro diagnostic kits, and lays the foundation for a continuous improvement process for in vitro diagnostic kits. It also demonstrates IntegraGen’s commitment to a proper industrial approach through the adoption of international quality standards and demonstrates the company’s ability to best meet the needs of its academic and industrial customers.
Read more here
Based in Evry Genopole, IntegraGen also has an U.S. office in Cambridge, Massachusetts.